Overview

Adherence solutions at their best

Established in 1993, Atlantis Healthcare has offices in the United Kingdom, Germany, Spain, Australia and New Zealand providing a unique service to address the issue of non-adherence.

We create engaging adherence programmes for patients and clinicians using our extensive research, profiling and in-depth understanding of treatment adherence. We build bespoke personalised programmes tailored to address the specific barriers to treatment adherence. Each programme captures the adherence profile of an individual patient, their medication and illness beliefs and their specific support needs. This ensures interventions address the underlying drivers of non-adherence on an individual patient basis to drive long-term behaviour change.

Innovation through to implementation

We have an end-to-end capability to design and manage your patient support programmes.

Experience across a wide range of disease states

Atlantis Healthcare has deployed over 70 programmes across 43 disease states including:
Glaucoma, Breast Cancer, Gout, Asthma, Pain, Growth Hormones, Osteoporosis, Wet AMD, Rheumatoid Arthritis, Lung Cancer, Haemophilia, Total Testosterone (TT), Alzheimer’s Disease, Incontinence, Lipid lowering, Hepatitis C, Erectile Dysfunction, Diabetes, Hearing Loss, health screenings, blood donor management and more.

Contact

Contact us to see how we can help you develop a patient support programme built from an evidence base and a unique understanding of patient psychology.